Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its c-terminal domain

被引:71
作者
Yu, IM
Gustafson, CLT
Diao, JB
Burgner, JW
Li, ZH
Zhang, JQ
Chen, J [1 ]
机构
[1] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
[2] Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA
[3] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA
[4] Zhongshan Univ, State Key Lab Biocontrol, Guangzhou, Peoples R China
关键词
D O I
10.1074/jbc.M501015200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The causative agent of severe acute respiratory syndrome (SARS) is the SARS-associated coronavirus, SARS-CoV. The viral nucleocapsid (N) protein plays an essential role in viral RNA packaging. In this study, recombinant SARS-CoV N protein was shown to be dimeric by analytical ultracentrifugation, size exclusion chromatography coupled with light scattering, and chemical cross-linking. Dimeric N proteins self-associate into tetramers and higher molecular weight oligomers at high concentrations. The dimerization domain of N was mapped through studies of the oligomeric states of several truncated mutants. Although mutants consisting of residues 1-210 and 1-284 fold as monomers, constructs consisting of residues 211-422 and 285-422 efficiently form dimers. When in excess, the truncated construct 285-422 inhibits the homodimerization of full-length N protein by forming a heterodimer with the full-length N protein. These results suggest that the N protein oligomerization involves the C-terminal residues 285-422, and this region is a good target for mutagenic studies to disrupt N protein self-association and virion assembly.
引用
收藏
页码:23280 / 23286
页数:7
相关论文
共 37 条
[1]   Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor [J].
Babcock, GJ ;
Esshaki, DJ ;
Thomas, WD ;
Ambrosino, DM .
JOURNAL OF VIROLOGY, 2004, 78 (09) :4552-4560
[2]   INTERACTIONS BETWEEN CORONAVIRUS NUCLEOCAPSID PROTEIN AND VIRAL RNAS - IMPLICATIONS FOR VIRAL TRANSCRIPTION [J].
BARIC, RS ;
NELSON, GW ;
FLEMING, JO ;
DEANS, RJ ;
KECK, JG ;
CASTEEL, N ;
STOHLMAN, SA .
JOURNAL OF VIROLOGY, 1988, 62 (11) :4280-4287
[3]   The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus [J].
Bos, ECW ;
Luytjes, W ;
VanderMeulen, H ;
Koerten, HK ;
Spaan, WJM .
VIROLOGY, 1996, 218 (01) :52-60
[4]   Identification of nucleocapsid binding sites within coronavirus-defective genomes [J].
Cologna, R ;
Spagnolo, JF ;
Hogue, BG .
VIROLOGY, 2000, 277 (02) :235-249
[5]   SEQUENCE DETERMINANTS OF CYTOSOLIC N-TERMINAL PROTEIN PROCESSING [J].
FLINTA, C ;
PERSSON, B ;
JORNVALL, H ;
VONHEIJNE, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 154 (01) :193-196
[6]  
Folta-Stogniew E, 1999, J Biomol Tech, V10, P51
[7]   Analysis of multimerization of the SARS coronavirus nucleocapsid protein [J].
He, RT ;
Dobie, F ;
Ballantine, M ;
Leeson, A ;
Li, Y ;
Bastien, N ;
Cutts, T ;
Andonov, A ;
Cao, JX ;
Booth, TF ;
Plummer, FA ;
Tyler, S ;
Baker, L ;
Li, XG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (02) :476-483
[8]   Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein [J].
He, RT ;
Leeson, A ;
Andonov, A ;
Li, Y ;
Bastien, N ;
Cao, JX ;
Osiowy, C ;
Dobie, F ;
Cutts, T ;
Ballantine, M ;
Li, XG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (04) :870-876
[9]   Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein [J].
Huang, QL ;
Yu, LP ;
Petros, AM ;
Gunasekera, A ;
Liu, ZH ;
Xu, N ;
Hajduk, P ;
Mack, J ;
Fesik, SW ;
Olejniczak, ET .
BIOCHEMISTRY, 2004, 43 (20) :6059-6063
[10]   The molecular biology of coronaviruses [J].
Lai, MMC ;
Cavanagh, D .
ADVANCES IN VIRUS RESEARCH, VOL 48, 1997, 48 :1-100